54 results
Page 2 of 3
DEF 14A
ejf espa5k7yf87wp
30 Apr 21
Definitive proxy
4:02pm
424B5
tad33b 5l5n97
21 Apr 21
Prospectus supplement for primary offering
4:45pm
424B5
nwwwo9
19 Apr 21
Prospectus supplement for primary offering
4:57pm
S-3ASR
wkiud2y6m7r ly77zvn
19 Apr 21
Automatic shelf registration
4:11pm
PRE 14A
6e4hovoo
14 Apr 21
Preliminary proxy
4:00pm
10-K
EX-10.20
q2ehgr
1 Mar 21
Annual report
12:00am
10-K
EX-10.30
5wzlg0vx
1 Mar 21
Annual report
12:00am
10-K
EX-10.29
dm4428c 8wvpxrgtwt8
1 Mar 21
Annual report
12:00am
10-K
yfzci65
1 Mar 21
Annual report
12:00am
424B5
h9tfyqyxgma
23 Sep 20
Prospectus supplement for primary offering
8:06am
424B5
49fgq9 3v
16 Sep 20
Prospectus supplement for primary offering
7:24am
6-K
EX-99.1
gjd8czs shi
16 Sep 20
Zai Lab Launches Hong Kong Secondary Listing
7:18am
6-K
EX-99.1
8euj4
11 Sep 20
Zai Lab Limited Supplemental and Updated Disclosures
8:09am
6-K
EX-99.1
vqf7htg16u3yghhlmn
8 Apr 20
Zai Lab obtains rights to develop and exclusively commercialize REGN1979 in oncology in mainland China, Hong Kong, Taiwan and Macau
6:03am
424B2
n4ifyx
24 Jan 20
Prospectus for primary offering
7:24am
424B5
mpphb4yk10dffsp
21 Jan 20
Prospectus supplement for primary offering
5:31pm